Skip to main content

Table 1 ROS signaling pathways

From: Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy

Signaling pathways

ROS targets

Effects

Related diseases

References

The NLRP3

inflammasome

signaling pathway

TRX;

mtDNA;

Ca2 + influx

Production of IL-1β and

IL-18;

initiation of pyroptosis

Diabetic nephropathy;

TRAPS;

osteoarthritis;

Alzheimer’s disease

[31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47]

NF-κB

signaling pathway

IκBα;

IKKβ;

NIK

M1

macrophage transcription;

induction of TNF-α, IL-1β, IL-6, IL-12 and COX-2 gene expression;

differentiation of Th1, Th17,

and Tfh cells

Inflammatory bowel disease;

arthritis;

sepsis;

gastritis;

asthma;

atherosclerosis

[6, 9, 48,49,50,51,52,53,54,55,56,57,58,59,60]

MAPKs

signaling pathway

ASK1;

mixed lineage kinase 3; growth factor receptors

M1

macrophage transcription;

production of TNF-α, IL-1β,

IL-8 and IL-10;

decrease in IL-12 and IFN-β production

Asthma;

TRAPS;

COPD

[6, 9, 37, 61,62,63,64,65,66,67,68,69,70]

JAK/STAT

signaling pathway

Activation of STAT by DNA methylation

Production of chemokines;

differentiation and apoptosis of hematopoietic cells

Rheumatoid arthritis;

psoriasis;

inflammatory bowel disease

[71,72,73,74,75,76,77,78,79,80,81,82]

Nrf2

signaling pathway

Keap1;

MAPKs;

PI3K;

NF-κB

Activation of heme

oxygenase-1, NADPH

dehydrogenase, SOD, and CAT

Acute lung injury;

nephritis;

osteoarthritis;

inflammatory bowel disease

[83,84,85,86,87,88,89,90,91,92,93,94,95,96]

PI3K/AKT

signaling pathway

Activation of PI3K;

phosphorylation of AKT;

inactivation of

phosphatase and tensin homology

Expression and activation of

inflammatory mediators;

recruitment of inflammatory

cells; airway remodeling;

corticosteroid insensitivity

Chronic inflammatory

respiratory diseases

[6, 9, 66, 97,98,99,100,101]